858 Therapeutics
PrivateLast Round
Series B
Sep 26, 2024
Total Funding Raised
$110M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
858 Therapeutics is a biotechnology company that develops small molecule therapeutics targeting novel oncology and immunology areas, including DNA damage response, innate immunity, and RNA modulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
858 Therapeutics Comparables
Compare 858 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 88% | |
| KSQ Therapeutics | 87% | |
| IDEAYA Biosciences, Inc. | 81% | |
858 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2024 | ||||
| Series A | Sep 21, 2021 |
858 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series B, Series A |
| Cormorant Asset Management | Series A |
| Avidity Partners | Series B |
| Logos Capital | Series B, Series A |
| Versant Ventures | Series B, Series A |
| Alexandria Venture Investments | Series B |
| Mirae Asset Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 35% MoM.
- May 18, 2026
Monthly visitors increased 151% MoM.
858 Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 858 Therapeutics's valuation, stock price, and market status.